Skip to main content


Page 4 of 20

  1. Lateral lymph node metastasis (LLNM) is frequent in papillary thyroid carcinoma (PTC) and is associated with a poor prognosis. This study aimed to developed a clinical-ultrasound (Clin-US) nomogram to predict ...

    Authors: Jialin Zhu, Luchen Chang, Dai Li, Bing Yue, Xueqing Wei, Deyi Li and Xi Wei
    Citation: Cancer Imaging 2023 23:55
  2. Axillary lymph node (ALN) metastasis is used to select treatment strategies and define the prognosis in breast cancer (BC) patients and is typically assessed using an invasive procedure. Noninvasive, simple, a...

    Authors: Xiaofeng Chen, Zhiqi Yang, Ruibin Huang, Yue Li, Yuting Liao, Guijin Li, Mengzhu Wang, Xiangguang Chen, Zhuozhi Dai and Weixiong Fan
    Citation: Cancer Imaging 2023 23:54
  3. Breast cancer is the most frequent cancer in women and remains the second leading cause of death in Western countries. It represents a heterogeneous group of diseases with diverse tumoral behaviour, treatment ...

    Authors: Dione Lother, Marie Robert, Elliot Elwood, Sam Smith, Nina Tunariu, Stephen R.D. Johnston, Marina Parton, Basrull Bhaludin, Thomas Millard, Kate Downey and Bhupinder Sharma
    Citation: Cancer Imaging 2023 23:53
  4. Local combined systemic therapy has been an important method for the treatment of unresectable hepatocellular carcinoma (HCC).The purpose of this study was to compare the effectiveness and safety of transarter...

    Authors: Liang Yin, Kai-Cai Liu, Wei-Fu Lv, Dong Lu, Yu-Lin Tan, Guo-Xiang Wang, Jia-Ying Dai, Xian-Hai Zhu and Bo Jiang
    Citation: Cancer Imaging 2023 23:52
  5. The ALBI-TAE model was recently proposed as a scoring system to select suitable patients with intermediate-stage hepatocellular carcinoma (HCC) for transarterial chemoembolization (TACE). However, this scoring...

    Authors: Kittipitch Bannangkoon, Keerati Hongsakul and Teeravut Tubtawee
    Citation: Cancer Imaging 2023 23:51
  6. Enchondromas (EC) and atypical cartilaginous tumours (ACT) of the knee joint represent benign/intermediate chondromatous neoplasms of the bone that are most commonly discovered incidentally. Based on small to ...

    Authors: Johannes Nikolaus Woltsche, Maria Anna Smolle, Dieter Szolar, Marko Bergovec and Andreas Leithner
    Citation: Cancer Imaging 2023 23:50
  7. CT prediction of resectability and prognosis following neoadjuvant treatment (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC) remains challenging. This study aims to determine whether addition of 18

    Authors: Jeongin Yoo, Jeong Min Lee, Ijin Joo, Dong Ho Lee, Jeong Hee Yoon, Mi Hye Yu, Jin-Young Jang and Sang Hyub Lee
    Citation: Cancer Imaging 2023 23:49
  8. CT-guided transthoracic core needle biopsy (TCNB) is a minimally invasive diagnostic procedure and a useful radiological method for diagnosing pleural lesions smaller than 10 mm in the presence of loculated pl...

    Authors: Melita Kukuljan, Ena Mršić and Eduard Oštarijaš
    Citation: Cancer Imaging 2023 23:48
  9. Authors: Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad and Håkan Ahlström
    Citation: Cancer Imaging 2023 23:46

    The original article was published in Cancer Imaging 2022 22:76

  10. Current studies indicate that fluorine-18-fluorodeoxyglucose positron emission tomography/ computed tomography ([18F]FDG PET/CT) is the most accurate imaging modality for the detection of relapsed locally advance...

    Authors: Alexander Brose, Kerstin Michalski, Juri Ruf, Marco Tosch, Susanne M. Eschmann, Mathias Schreckenberger, Jochem König, Ursula Nestle and Matthias Miederer
    Citation: Cancer Imaging 2023 23:45
  11. Chimeric antigen receptor T-cell therapy (CART) prolongs survival for patients with refractory or relapsed lymphoma. Discrepancies among different response criteria for lymphoma under CART were recently shown....

    Authors: Michael Winkelmann, Viktoria Blumenberg, Kai Rejeski, Veit L. Bücklein, Maria Ingenerf, Marcus Unterrainer, Christian Schmidt, Franziska J. Dekorsy, Peter Bartenstein, Jens Ricke, Michael von Bergwelt-Baildon, Marion Subklewe and Wolfgang G. Kunz
    Citation: Cancer Imaging 2023 23:44
  12. The worldwide increase of pancreatic ductal adenocarcinoma (PDAC), which still has one of the lowest survival rates, requires novel imaging tools to improve early detection and to refine diagnosis. Therefore, ...

    Authors: Diana Pinkert-Leetsch, Jasper Frohn, Philipp Ströbel, Frauke Alves, Tim Salditt and Jeannine Missbach-Guentner
    Citation: Cancer Imaging 2023 23:43
  13. To assess the feasibility of the cine MR feature tracking technique for the evaluation of cardiovascular-induced morphological deformation in the diagnosis of thymic epithelial tumors (TETs).

    Authors: Koji Takumi, Hiroaki Nagano, Akie Mukai, Kazuhiro Ueda, Kazuhiro Tabata and Takashi Yoshiura
    Citation: Cancer Imaging 2023 23:42
  14. The aim of this retrospective study was to compare the diagnostic accuracy of somatostatin receptor (SSR)-PET/CT to liver MRI as reference standard in the evaluation of hepatic involvement in neuroendocrine tu...

    Authors: Freba Grawe, Natalie Rosenberger, Maria Ingenerf, Leonie Beyer, Ralf Eschbach, Andrei Todica, Ricarda Seidensticker, Christine Schmid-Tannwald, Clemens C. Cyran, Jens Ricke, Peter Bartenstein, Christoph. J. Auernhammer, Johannes Ruebenthaler and Matthias P. Fabritius
    Citation: Cancer Imaging 2023 23:41
  15. Clinically significant portal hypertension (CSPH) has been identified as an important prognostic factor in patients with hepatocellular carcinoma (HCC) undergoing curative treatment. This study aimed to assess...

    Authors: Lukas Müller, Simon J. Gairing, Friedrich Foerster, Arndt Weinmann, Jens Mittler, Fabian Stoehr, Dirk Graafen, Christoph Düber, Peter R. Galle, Roman Kloeckner and Felix Hahn
    Citation: Cancer Imaging 2023 23:40
  16. Dual Energy Computed Tomography (DECT) is a technology that allows for viewing computed tomography spectral images. This method, due to ability of presenting specific elements and substances (like water, calci...

    Authors: Adam Daniel Durma, Marek Saracyn, Arkadiusz Zegadło and Grzegorz Kamiński
    Citation: Cancer Imaging 2023 23:39
  17. The advent of next-generation computed tomography (CT)- and magnetic resonance imaging (MRI) opened many new perspectives in the evaluation of tumor characteristics. An increasing body of evidence suggests the...

    Authors: Vitali Koch, Nils Weitzer, Daniel Pinto Dos Santos, Leon D. Gruenewald, Scherwin Mahmoudi, Simon S. Martin, Katrin Eichler, Simon Bernatz, Tatjana Gruber-Rouh, Christian Booz, Renate M. Hammerstingl, Teodora Biciusca, Nicolas Rosbach, Aynur Gökduman, Tommaso D’Angelo, Fabian Finkelmeier…
    Citation: Cancer Imaging 2023 23:38
  18. Neuronavigation of preoperative MRI is limited by several errors. Intraoperative ultrasound (iUS) with navigated probes that provide automatic superposition of pre-operative MRI and iUS and three-dimensional i...

    Authors: Edoardo Mazzucchi, Patrick Hiepe, Max Langhof, Giuseppe La Rocca, Fabrizio Pignotti, Pierluigi Rinaldi and Giovanni Sabatino
    Citation: Cancer Imaging 2023 23:37
  19. Global energy balance is a vital process tightly regulated by the brain that frequently becomes dysregulated during the development of cancer. Glioblastoma (GBM) is one of the most investigated malignancies, b...

    Authors: Irene Guadilla, Sara González, Sebastián Cerdán, Blanca Lizarbe and Pilar López-Larrubia
    Citation: Cancer Imaging 2023 23:36
  20. The efficacy of 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography/Computed Tomography(PET/CT) in evaluating the neck status in clinically node-negative (cN0) oral squamous cell carcinoma(OSCC) patient...

    Authors: Feng Xu, Liling Peng, Junyi Feng, Xiaochun Zhu, Yifan Pan, Yuhua Hu, Xin Gao, Yubo Ma and Yue He
    Citation: Cancer Imaging 2023 23:34

    The Correction to this article has been published in Cancer Imaging 2023 23:47

  21. Several previous studies demonstrated that the combination of self-expandable metallic stents (SEMS) and 125I seed implantation might prolong stent patency and obtain survival benefits for malignant obstructive j...

    Authors: Ye Sheng, Xiaobo Fu, Guobao Wang, Maoyuan Mu, Weiwei Jiang, Zixiong Chen, Han Qi and Fei Gao
    Citation: Cancer Imaging 2023 23:33
  22. To assess volumetric ablation margins derived from intraoperative pre- and post-ablation MRI after magnetic resonance imaging (MRI)-guided percutaneous cryoablation of renal tumors and explore its correlation ...

    Authors: Nienke S. de Jager, Tim J. van Oostenbrugge, Torben Pätz, Sjoerd F. M. Jenniskens, Jurgen J. Fütterer, Johan F. Langenhuijsen and Christiaan G. Overduin
    Citation: Cancer Imaging 2023 23:31
  23. Early evaluation of the efficacy of first-line chemotherapy combined with bevacizumab in patients with colorectal cancer liver metastasis (CRLM) remains challenging. This study used 2-month post-chemotherapy s...

    Authors: Shenglin Li, Long Yuan, Mengying Yue, Yuan Xu, Suwei Liu, Feng Wang, Xiaoqin Liu, Fengyan Wang, Juan Deng, Qiu Sun, Xianwang Liu, Caiqiang Xue, Ting Lu, Wenjuan Zhang and Junlin Zhou
    Citation: Cancer Imaging 2023 23:30
  24. Hypoperfusion or resultant hypoxia in solid tumours is a main reason for therapeutic resistance. Augmenting the blood perfusion of hypovascular tumours might improve both hypoxia and drug delivery. Cavitation ...

    Authors: Najiao Tang, Jiawei Tang, Junhui Tang, Qiong Zhu, Xiaoxiao Dong, Yi Zhang, Ningshan Li and Zheng Liu
    Citation: Cancer Imaging 2023 23:29
  25. Recently introduced long-axial field-of-view (LAFOV) PET/CT systems represent one of the most significant advancements in nuclear medicine since the advent of multi-modality PET/CT imaging. The higher sensitiv...

    Authors: Ian Alberts, Hasan Sari, Clemens Mingels, Ali Afshar-Oromieh, Thomas Pyka, Kuangyu Shi and Axel Rominger
    Citation: Cancer Imaging 2023 23:28
  26. Radiotherapy (RT) and surgery are potential treatment options in patients with biochemical recurrence (BCR) following primary prostate cancer treatment. This study examines the value of prostate-specific membr...

    Authors: Sara Harsini, Don Wilson, Heather Saprunoff, Hayley Allan, Martin Gleave, Larry Goldenberg, Kim N. Chi, Charmaine Kim-Sing, Scott Tyldesley and François Bénard
    Citation: Cancer Imaging 2023 23:27
  27. Carotid artery invasion (CAI) has been demonstrated to be an important prognosticator in some head and neck cancers. This study aimed to examine the prognostic value of radiologic CAI (rCAI) by cervical lympha...

    Authors: Wenze Qiu, Xi Zhong, Jiali Jiang, Laiji Huang, Jiansheng Li, Ronghui Zheng, Zhuochen Cai and Yawei Yuan
    Citation: Cancer Imaging 2023 23:26
  28. Ductal lesions are an important, often overlooked, and poorly understood issue in breast imaging, which have a risk of underlying malignancy ranging from 5 to 23%. Ultrasonography (US), which has largely repla...

    Authors: Bo Wang, Di Yang, Xuan Zhang, XuanTong Gong, Tong Xu, Jie Han, YinPeng Ren, ShuangMei Zou, Lin Li and Yong Wang
    Citation: Cancer Imaging 2023 23:25
  29. This study evaluated the performance of the contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) in patients without LI-RADS-defined hepatocellular carcinoma (HCC) risk factors...

    Authors: Zhe Huang, Ping Ping Zhou, Shan Shan Li and Kaiyan Li
    Citation: Cancer Imaging 2023 23:24
  30. To compare different response criteria using computed tomography (CT) and positron emission tomography (PET) in measuring response and survival in the early phase after programmed death-1 (PD-1) blockade monot...

    Authors: Kyoichi Kaira, Ou Yamaguchi, Ichiro Naruse, Yukihiro Umeda, Takeshi Honda, Satoshi Watanabe, Kosuke Ichikawa, Shin Yanagisawa, Norimitsu Kasahara, Tetsuya Higuchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Atsuto Mouri, Hisao Imai, Kunihiko Iizuka…
    Citation: Cancer Imaging 2023 23:23
  31. We aimed to prospectively compare the diagnostic performance of gadoxetic acid-enhanced MRI (EOB-MRI) and contrast-enhanced Computed Tomography (CECT) for hepatocellular carcinoma (HCC) detection and liver tra...

    Authors: Kartik S. Jhaveri, Ali Babaei Jandaghi, Rajesh Bhayana, Khaled Y. Elbanna, Osvaldo Espin-Garcia, Sandra E. Fischer, Anand Ghanekar and Gonzalo Sapisochin
    Citation: Cancer Imaging 2023 23:22
  32. To explore the prognostic role of FDG PET/CT maximal standard uptake values of metastatic lesions (SUVmax-M) in patients with de novo metastatic nasopharyngeal carcinoma (mNPC) following palliative chemotherap...

    Authors: Wenbin Yan, Chunhua Sun, Xiaomin Ou and Chaosu Hu
    Citation: Cancer Imaging 2023 23:21
  33. Although some studies have assessed the correlation between computed tomography (CT) features and anaplastic lymphoma kinase (ALK) rearrangement in patients with non-small-cell lung cancer (NSCLC), few have fo...

    Authors: Xiaoming Hou, Han Chen, You Liu, Sandong Gong, Meizi Zhudai and Leilei Shen
    Citation: Cancer Imaging 2023 23:20
  34. Raltitrexed shows therapeutic effects and safety in many types of malignant tumors. However, reports of the clinical outcomes of raltitrexed-based transarterial chemoembolization (TACE) or drug-eluting beads T...

    Authors: Yonghua Bi, Yang Wang, Wenguang Zhang, Huibin Lu, Jianzhuang Ren and Xinwei Han
    Citation: Cancer Imaging 2023 23:19
  35. Patients with colorectal liver metastases (CRLM) combined with hepatic lymph node (HLN) metastases have a poor prognosis. In this study, we developed and validated a model using clinical and magnetic resonance...

    Authors: Hai-bin Zhu, Da Xu, Xue-Feng Sun, Xiao-Ting Li, Xiao-Yan Zhang, Kun Wang, Bao-Cai Xing and Ying-Shi Sun
    Citation: Cancer Imaging 2023 23:18
  36. Although MRI is a radiation-free imaging modality, it has historically been limited in lung imaging due to inherent technical restrictions. The aim of this study is to explore the performance of lung MRI in de...

    Authors: Felipe Sanchez, Pascal N. Tyrrell, Patrick Cheung, Chinthaka Heyn, Simon Graham, Ian Poon, Yee Ung, Alexander Louie, May Tsao and Anastasia Oikonomou
    Citation: Cancer Imaging 2023 23:17
  37. Appropriate preoperative identification of iCCA subtype is essential for personalized management, so the aim of this study is to investigate the role of MR imaging features in preoperatively differentiating th...

    Authors: Yuyao Xiao, Changwu Zhou, Xiaoyan Ni, Peng Huang, Fei Wu, Chun Yang and Mengsu Zeng
    Citation: Cancer Imaging 2023 23:15
  38. The purpose of this study was to explore whether incorporating the peritumoral region to train deep neural networks could improve the performance of the models for predicting the prognosis of NPC.

    Authors: Song Li, Xia Wan, Yu-Qin Deng, Hong-Li Hua, Sheng-Lan Li, Xi-Xiang Chen, Man-Li Zeng, Yunfei Zha and Ze-Zhang Tao
    Citation: Cancer Imaging 2023 23:14
  39. To analyse the predictive effect of a nomogram combining dual-layer spectral computed tomography (DSCT) quantitative parameters with typical radiological features in distinguishing benign micro-nodule from thy...

    Authors: Zuhua Song, Qian Li, Dan Zhang, Xiaojiao Li, Jiayi Yu, Qian Liu, Zongwen Li, Jie Huang, Xiaodi Zhang and Zhuoyue Tang
    Citation: Cancer Imaging 2023 23:13
  40. Metastatic bone disease (MBD) is the most common form of metastases, most frequently deriving from prostate cancer. MBD is screened with bone scintigraphy (BS), which have high sensitivity but low specificity ...

    Authors: Abdalla Ibrahim, Akshayaa Vaidyanathan, Sergey Primakov, Flore Belmans, Fabio Bottari, Turkey Refaee, Pierre Lovinfosse, Alexandre Jadoul, Celine Derwael, Fabian Hertel, Henry C. Woodruff, Helle D. Zacho, Sean Walsh, Wim Vos, Mariaelena Occhipinti, François-Xavier Hanin…
    Citation: Cancer Imaging 2023 23:12
  41. Accurate staging and response assessment are essential for prognosis and to guide treatment in patients with lymphoma. The aim of this study was to compare the diagnostic performance of FDG PET/MRI versus FDG ...

    Authors: Vijay Mistry, Justin R. Scott, Tzu-Yang Wang, Peter Mollee, Kenneth A. Miles, W. Phillip Law and Greg Hapgood
    Citation: Cancer Imaging 2023 23:11
  42. The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are a first-line therapy for non-small cell lung cancer (NSCLC) with EGFR mutations. Approximately half of the patients with EGFR-muta...

    Authors: Chia-Feng Lu, Chien-Yi Liao, Heng-Sheng Chao, Hwa-Yen Chiu, Ting-Wei Wang, Yen Lee, Jyun-Ru Chen, Tsu-Hui Shiao, Yuh-Min Chen and Yu-Te Wu
    Citation: Cancer Imaging 2023 23:9
  43. The evaluation of treatment response according to METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) criteria is an important but time-consuming task for patients with advanced prostate canc...

    Authors: Xiang Liu, Zemin Zhu, Kexin Wang, Yaofeng Zhang, Jialun Li, Xiangpeng Wang, Xiaodong Zhang and Xiaoying Wang
    Citation: Cancer Imaging 2023 23:7
  44. Deep-learning-based computer-aided diagnosis (DL-CAD) systems using MRI for prostate cancer (PCa) detection have demonstrated good performance. Nevertheless, DL-CAD systems are vulnerable to high heterogeneiti...

    Authors: Lei Hu, Caixia Fu, Xinyang Song, Robert Grimm, Heinrich von Busch, Thomas Benkert, Ali Kamen, Bin Lou, Henkjan Huisman, Angela Tong, Tobias Penzkofer, Moon Hyung Choi, Ivan Shabunin, David Winkel, Pengyi Xing, Dieter Szolar…
    Citation: Cancer Imaging 2023 23:6

Official journal of

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.636 - SNIP (Source Normalized Impact per Paper)
    1.231 - SJR (SCImago Journal Rank)

    2023 Speed
    13 days submission to first editorial decision for all manuscripts (Median)
    123 days submission to accept (Median)

    2023 Usage 
    349 Altmetric mentions 

Download journal leaflet